drugset
drugset / Trial / NCT00626834

Vigabatrin Ph 1 Cocaine Interaction Study

NCT00626834 ↗

Phase 1 Completed 24 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupDouble-blindBasic science

Summary

This is a Phase 1 safety/tolerably study to determine if there are clinically significant interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent with intravenous (IV) cocaine infusions.

Timeline

Start
2008-02
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vigabatrin Small molecule — Oral

Indications

cocaine dependence